Eli Lilly's (LLY) CFO Anat Ashkenazi resigns. CHMP recommends the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Tagrisso.
Data from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.
Finding the right investments can be a challenge, but I've found one FTSE 100 stock that ticks all the boxes for my long-term portfolio. The post I’d buy this FTSE 100 stock without hesitation appeared first on The Motley Fool UK.